Efficacy and Safety of Mycophenolate Mofetil in Children with Steroid Dependent Nephrotic Syndrome

Purpose: Steroid dependent nephrotic syndrome (SDNS) is a chronic illness in childhood hard to treat. Steroid sparing drugs are often used, because long-term steroid therapy can cause severe side effects. We studied to compare efficacy between MMF and other drugs including cyclosporine and levamisol...

Full description

Bibliographic Details
Published in:	Childhood Kidney Diseases
Main Authors:	Taek Jin Lim, Seong Heon Kim, Su Young Kim
Format:	Article
Language:	English
Published:	Korean Society of Pediatric Nephrology 2015-10-01
Subjects:	steroid dependent nephrotic syndrome mmf cylclosporine levamisole
Online Access:	http://www.chikd.org/upload/ckd-19-2-105.pdf

Similar Items

Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report
by: Mohammad Firoz Anjum, et al.
Published: (2024-07-01)

Use of levamisole in children with nephrotic syndrome: A retrospective study to examine its adverse effects in children with nephrotic syndrome
by: Suprita Kalra, et al.
Published: (2017-01-01)

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
by: Jide Song, et al.
Published: (2025-08-01)

Predictive risk factors of steroid dependent nephrotic syndrome in children with idiopathic nephrotic syndrome
by: Ehsan Valavi, et al.
Published: (2023-06-01)

Effects of Rituximab Including Long-term Maintenance Therapy in Children with Nephrotic Syndrome in a Single Center of Korea
by: Seong Heon Kim, et al.
Published: (2018-04-01)

Clinical case of steroid-dependent nephrotic syndrome in a child
by: Ye. Lagodych, et al.
Published: (2023-06-01)

Predictive risk factors of steroid dependent nephrotic syndrome in children
by: Maher Ahmed Abdel-Hafez, et al.
Published: (2017-07-01)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
by: Hongzhen Zhong, et al.
Published: (2019-10-01)

Efficacy of Levamisole as a single agent in maintaining remission in steroid dependant nephrotic syndrome
by: S. T. Kudagammana, et al.
Published: (2017-06-01)

Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
by: Gurdeep Singh Dhooria, et al.
Published: (2024-09-01)

Rituximab in childhood steroid-dependent nephrotic syndrome: a single-center experience
by: Shrouq Badr, et al.
Published: (2025-09-01)

Long-term efficacy of Rituximab in steroid dependent and frequent relapsing adult nephrotic syndrome
by: Omri Feder, et al.
Published: (2025-03-01)

Medium-Term Outcome of Cyclosporine in Children with Steroid-Dependent Nephrotic Syndrome: Single Centre experience from Pakistan
by: Saima Kashif, et al.
Published: (2023-10-01)

Lipoprotein (a) as a Predictor of Steroid Dependence in Paediatric Steroid Sensitive Nephrotic Syndrome
by: Surupa Basu, et al.
Published: (2021-01-01)

Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials
by: Jessica Felicia Ang, et al.
Published: (2024-04-01)

Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
by: Joshua Kleine, et al.
Published: (2022-04-01)

Therapeutic efficacy of low-dose rituximab for steroid-dependent minimal-change nephrotic syndrome in adults
by: Li Xiao-wei, et al.
Published: (2021-01-01)

The efficacy and dynamic changes of immune function of rituximab with mycophenolate mofetil in the treatment of steroid-dependent /frequently relapsing nephrotic syndrome: a retrospective follow-up study
by: Songlei Gu, et al.
Published: (2025-04-01)

Administration of enteric-coated mycophenolate sodium in children with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis
by: Maria Gracia Caletti, et al.
Published: (2018-07-01)

Levamisole Modulation of Podocytes’ Actin Cytoskeleton in Nephrotic Syndrome
by: Susan T. Veissi, et al.
Published: (2023-11-01)

Long Term Evaluations of First Single-dose Rituximab in Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome
by: Xiao-Ling Niu, et al.
Published: (2024-12-01)

Use of urinary NGAL in steroid-resistant vs. steroid-sensitive nephrotic syndrome: a systematic review and meta-analysis
by: Aymen Abdalla, et al.
Published: (2025-08-01)

Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
by: Behnam Ermian, et al.
Published: (2025-02-01)

Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome
by: Silvia Bernardi, et al.
Published: (2022-05-01)

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-02-01)

Amino acid variants in the HLA-DQA1 and HLA-DQB1 molecules explain the major association of variants with relapse status in pediatric patients with steroid-sensitive nephrotic syndrome
by: Hui Yin, et al.
Published: (2025-03-01)

The Potential of Vitamin-D-Binding Protein as a Urinary Biomarker to Distinguish Steroid-Resistant from Steroid-Sensitive Idiopathic Nephrotic Syndrome in Iraqi Children
by: Ali Mohammed Abd Alridha, et al.
Published: (2023-04-01)

Short-term outcome of levamisole in frequently relapsing nephrotic syndrome: a single-center prospective cohort study
by: Sabeeta Khatri, et al.
Published: (2025-03-01)

Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens
by: Valeria Chirico, et al.
Published: (2025-07-01)

Predictive Parameters of Steroid Dependency in Minimal Change Disease
by: Esra Nagehan Akyol Önder, et al.
Published: (2022-12-01)

Machine learning models for predicting steroid-resistant of nephrotic syndrome
by: Qing Ye, et al.
Published: (2023-01-01)

Idiopathic Nephrotic Syndrome in Childhood: A Retrospective Analysis of Two Hundred and Eighty Nine Patients
by: Kenan Yılmaz, et al.
Published: (2017-12-01)

A rare cause of steroid-resistant nephrotic syndrome – a case report
by: Paulina Kuran, et al.
Published: (2023-06-01)

Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis
by: Yu Zhu, et al.
Published: (2024-02-01)

A Cross-Sectional Study of Urinary Neutrophil Gelatinase-Associated Lipocalin and its Association with Steroid Responsiveness in Iraqi Children with Idiopathic Nephrotic Syndrome
by: ALI MOHAMMED ABD ALRIDHA, et al.
Published: (2023-10-01)

Bilateral Pulmonary Embolism in a 12-Year-Old Girl with Steroid-Resistant Nephrotic Syndrome
by: Osama Y. Safdar, et al.
Published: (2020-06-01)

Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2
by: Mengyuan Wu, et al.
Published: (2025-03-01)

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
by: China Nagano, et al.
Published: (2019-08-01)

Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy
by: Jing Miao, et al.
Published: (2024-01-01)

Study of steroid-resistant nephrotic syndrome: a single center experience
by: Youmna Ahmed Hassan Elbeltagi, et al.
Published: (2024-06-01)